We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

27 hedge funds and large institutions have $8.08M invested in ImmuCell in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

8% more funds holding

Funds holding: 25 → 27 (+2)

0.33% less ownership

Funds ownership: 14.52% → 14.19% (-0.33%)

10% less capital invested

Capital invested by funds: $9M → $8.08M (-$923K)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
S
Steadtrust
Texas
+$200K
2
SFS
Strategic Financial Services
New York
+$37.9K
3
BlackRock
BlackRock
New York
+$2.78K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.07K
5
Morgan Stanley
Morgan Stanley
New York
+$1.26K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$123K
2
PP
Prosperity Planning
Missouri
-$111K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$48.3K
4
DIG
Dauntless Investment Group
New Hampshire
-$47.9K
5
UBS Group
UBS Group
Switzerland
-$46.7K

ICCC Hedge Fund Activity: Q3 2025 in Review

27 of the 7,646 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2025, worth a combined $8.08M — down 10% from $9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCC positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Steadtrust, opening a new position worth an estimated $200K. The largest seller was Citadel Advisors, cutting an estimated $123K.

  • 27 institutional investors held ImmuCell (ICCC) as of Q3 2025, up from 25 in Q2 2025.
  • Funds reported $8.08M of ImmuCell stock for Q3 2025, down 10% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q3 2025 and 2 closed out, a net change of +2 holders.
  • The largest ImmuCell buyer in Q3 2025 was Steadtrust, an estimated $200K added.
  • The largest ImmuCell seller in Q3 2025 was Citadel Advisors, an estimated $123K sold.

Based on aggregated 13F filings for Q3 2025.